The pyruvate dehydrogenase kinase inhibitor dichloroacetate mitigates alcohol-induced hepatic inflammation and metabolic disturbances in mice.

MLA

Wu, Jianguo, et al. “The Pyruvate Dehydrogenase Kinase Inhibitor Dichloroacetate Mitigates Alcohol-Induced Hepatic Inflammation and Metabolic Disturbances in Mice.” Hepatology Communications, vol. 8, no. 12, Nov. 2024. EBSCOhost, https://doi.org/10.1097/HC9.0000000000000547.

APA

Wu, J., Huang, E., McMullen, M. R., Singh, V., Mrdjen, M., Bellar, A., Wang, L., Welch, N., Dasarathy, J., Dasarathy, S., Streem, D., Brown, J. M., & Nagy, L. E. (2024). The pyruvate dehydrogenase kinase inhibitor dichloroacetate mitigates alcohol-induced hepatic inflammation and metabolic disturbances in mice. Hepatology Communications, 8(12). https://doi.org/10.1097/HC9.0000000000000547

Chicago

Wu, Jianguo, Emily Huang, Megan R McMullen, Vaibhav Singh, Marko Mrdjen, Annette Bellar, Li Wang, et al. 2024. “The Pyruvate Dehydrogenase Kinase Inhibitor Dichloroacetate Mitigates Alcohol-Induced Hepatic Inflammation and Metabolic Disturbances in Mice.” Hepatology Communications 8 (12). doi:10.1097/HC9.0000000000000547.